HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16.

Abstract
Trisomy 22 is an uncommon chromosomal abnormality in acute myeloid leukemia. Recent studies, however, have shown an association between trisomy 22 and acute myeloid leukemia with a monocytic component, and in particular, acute myelomonocytic leukemia with marrow eosinophilia. Furthermore, it has also been suggested that trisomy 22 was in fact only a secondary chromosomal change occurring in acute myeloid leukemia with inv(16). In this report, we analyze the morphological, cytogenetic, and molecular findings of three cases of acute myeloid leukemia with trisomy 22 but without cytogenetic evidence of inv(16). The results indicate a consistent association between trisomy 22 and inv(16), the latter being cytogenetically cryptic in some cases. This finding is of potential diagnostic and therapeutic significance.
AuthorsK F Wong, Y L Kwong
JournalCancer genetics and cytogenetics (Cancer Genet Cytogenet) Vol. 109 Issue 2 Pg. 131-3 (Mar 1999) ISSN: 0165-4608 [Print] United States
PMID10087946 (Publication Type: Journal Article)
Chemical References
  • Genetic Markers
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Chromosome Inversion
  • Chromosomes, Human, Pair 16
  • Chromosomes, Human, Pair 22
  • Genetic Markers
  • Humans
  • Leukemia, Myeloid (genetics, pathology)
  • Male
  • Monocytes (pathology)
  • Polymerase Chain Reaction
  • Trisomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: